| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Allocation of Income and Absence of Dividends | For |
| O.3 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.4 | Approve Compensation Report of Corporate Officers | Oppose |
| O.5 | Approve Compensation of Denis Kessler, Chairman and CEO | Oppose |
| O.6 | Approve Remuneration Policy of Directors | For |
| O.7 | Approve Remuneration Policy of Denis Kessler, Chairman and CEO | Oppose |
| O.8 | Reelect Vanessa Marquette as Director | For |
| O.9 | Reelect Holding Malakoff Humanis as Director | Oppose |
| O.10 | Reelect Zhen Wang as Director | For |
| O.11 | Elect Natacha Valla as Director | For |
| O.12 | Appoint KPMG as Auditor | For |
| O.13 | Appoint Mazars as Auditor | Oppose |
| O.14 | Acknowledge End of Mandate of Olivier Drion as Alternate Auditor and Decision Not to Replace | For |
| O.15 | Acknowledge End of Mandate of Lionel Gotlib as Alternate Auditor and Decision Not to Replace | For |
| O.16 | Authorise Share Repurchase | Oppose |
| E.17 | Authorize Capitalization of Reserves of Up to EUR 200 Million for Bonus Issue or Increase in Par Value | For |
| E.18 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 589,353,524 | For |
| E.19 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 147,338,381 | Oppose |
| E.20 | Approve Issuance of Equity or Equity-Linked Securities for up to 10 Percent of Issued Capital Per Year for Qualified Investors | Oppose |
| E.21 | Authorize Capital Increase of Up to EUR 147,338,381 for Future Exchange Offers | Oppose |
| E.22 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | For |
| E.23 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Oppose |
| E.24 | Authorize Issuance of Warrants (Bons 2020 Contingents) without Preemptive Rights Reserved for Specific Beneficiaries up to Aggregate Nominal Amount of EUR 300 Million | Oppose |
| E.25 | Authorize Issuance of Warrants (Bons 2020 AOF) without Preemptive Rights Reserved for Specific Beneficiaries up to Aggregate Nominal Amount of EUR 300 Million | Oppose |
| E.26 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares | For |
| E.27 | Authorize up to 1.5 Million Shares for Use in Stock Option Plans | Oppose |
| E.28 | Authorize up to 3 Million Shares for Use in Restricted Stock Plans | Oppose |
| E.29 | Approve Issue of Shares for Employee Saving Plan | Oppose |
| E.30 | Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 18-25, 27 and 29 at EUR 772,138,280 | For |
| E.31 | Amend Article 7 of Bylaws Re: Shareholding Disclosure Thresholds | For |
| E.32 | Amend Articles 7, 10, 11, 13, 15, 18 of Bylaws to Comply with Legal Changes | For |
| E.33 | Authorize Filing of Required Documents/Other Formalities | For |
